Randomized, Double-Blind, Placebo-Controlled Trial of Erythropoietin in Non–Small-Cell Lung Cancer With Disease-Related Anemia

R. Wright, James; Ung, Yee; A. Julian, Jim; I. Pritchard, Kathleen; J. Whelan, Timothy; Douglas Smith, C.; Szechtman, Barbara; Roa, Wilson; Mulroy, Liam; Rudinskas, Leona; Gagnon, Bruno; S. Okawara, Gord; N. Levine, Mark

doi:10.1200/jco.2006.07.1514

Public

Randomized, Double-Blind, Placebo-Controlled Trial of Erythropoietin in Non–Small-Cell Lung Cancer With Disease-Related Anemia

Published in Journal of Clinical Oncology • Feb 21, 2007

Authors:

James R. Wright

Yee Ung

Jim A. Julian

Abstract

PURPOSE: Previous trials have suggested a quality-of-life (QOL) improvement for anemic cancer patients treated with erythropoietin, but few used QOL as the primary outcome. We designed a trial to investigate the effects of epoetin alfa therapy on the QOL of anemic patients with advanced non-small-ce...

Subject

Medicine

Epoetin alfa

Placebo

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!